Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00275834 · ClinicalTrials.gov registry record · NA

Zonisamide for Weight Reduction in Obese Adults

A NA study, sponsored by Duke University.

Completed
Registry status
NA
Development phase
225
Enrollment target

NCT00275834: Completed NA study, sponsored by Duke University.

NCT00275834 is a NA study that has completed, run by Duke University. The registered enrollment target is 225 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (84% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00275834, a NA study, has completed, sponsored by Duke University.

COMPLETED
Registry status
NA
Development phase
225 participants
Enrollment target

Study Summary

The primary aim of this study is to assess long-term weight loss efficacy of zonisamide relative to placebo in obese patients prescribed a dietary intervention.

Primary Outcome

The primary endpoint was weight loss at 1-year, Month-12 weight minus baseline weight, in kilograms.

Interventions

  • DRUG Zonisamide

Trial Details

FieldValue
Enrollment Target 225 participants
Start Date 2006-01
Est. Completion 2011-09
Phase NA
Duke University

1,725 total trials

What the finished NCT00275834 record still lists

NCT00275834 is an interventional study that assigns participants to a tested intervention. The registered 225 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (84% lower).

The record links to 0 conditions, and to 1 intervention - of which Zonisamide is the first listed.

NCT00275834 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT00275834 about?

NCT00275834 is a clinical study titled "Zonisamide for Weight Reduction in Obese Adults". The primary aim of this study is to assess long-term weight loss efficacy of zonisamide relative to placebo in obese patients prescribed a dietary intervention.

What is the current status of trial NCT00275834?

This trial is currently completed. It is a NA study. The enrollment target is 225 participants. The study started on 2006-01. Estimated completion is 2011-09.

What interventions are being tested in trial NCT00275834?

The interventions under investigation include: Zonisamide (DRUG).

Who is sponsoring clinical trial NCT00275834?

This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT00275834's enrollment target sits among peer trials

225 472nd of 2000 higher than 1,523 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03955445 · 225 participants · Phase 3

    Long-term Efficacy, Safety and Tolerability of Iptacopan in C3G or IC-MPGN

  • NCT04054310 · 225 participants · NA

    Non-Invasive Quantification of Liver Health in NASH (N-QUAN)

  • NCT04480554 · 225 participants · Phase 2

    Anti-retroviral Therapy, Medications for Opioid Use Disorder, Opioids and HIV Infection - Study 1

  • NCT04888104 · 225 participants

    Prospective, Multicenter, Case-Control Analysis of the VersaTie Posterior Fixation System to Prevent Proximal Junctional Failure in Long Posterior Spinal Fusion Constructs for Adult Patients

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00275834, the US trial registry maintained by the National Library of Medicine. NCT00275834 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.